Inhibikase Therapeutics (IKT)
(Real Time Quote from BATS)
$1.59 USD
-0.07 (-4.22%)
Updated Oct 6, 2025 03:36 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
IKT 1.59 -0.07(-4.22%)
Will IKT be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for IKT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IKT
Inhibikase Therapeutics (IKT) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
IKT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for IKT
IKT forms 20 Day Moving Average Support on October 3
Is IKT set to rally? Crossed Above 20 Day Moving Average shows up after climbing 1.86%
MACD Bullish Signal Line Cross appears for IKT after 0.62% move
Crossed Above 20 Day Moving Average appears for IKT after 5.88% move
Is IKT compressing before expansion? NR7 shows up after dropping 1.29%